BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 20465658)

  • 1. Prevention and treatment of systemic glucocorticoid side effects.
    Moghadam-Kia S; Werth VP
    Int J Dermatol; 2010 Mar; 49(3):239-48. PubMed ID: 20465658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and treatment of glucocorticoid-induced osteoporosis in daily dermatologic practice.
    Vermaat H; Kirtschig G
    Int J Dermatol; 2008 Jul; 47(7):737-42. PubMed ID: 18613886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients.
    Yosipovitch G; Hoon TS; Leok GC
    Arch Dermatol; 2001 Apr; 137(4):477-81. PubMed ID: 11295929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic glucocorticoids: important issues and practical guidelines for the dermatologist.
    Dodiuk-Gad RP; Ish-Shalom S; Shear NH
    Int J Dermatol; 2015 Jun; 54(6):723-9. PubMed ID: 25683616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid-induced bone loss in dermatologic patients: an update.
    Summey BT; Yosipovitch G
    Arch Dermatol; 2006 Jan; 142(1):82-90. PubMed ID: 16415391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive techniques to limit glucocorticoid-induced side effects.
    Vittorio CC; Werth VP
    Adv Dermatol; 2000; 16():273-97; discussion 298. PubMed ID: 11094631
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events.
    Fardet L; Fève B
    Drugs; 2014 Oct; 74(15):1731-45. PubMed ID: 25204470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroids: a review with emphasis on complications of prolonged systemic therapy.
    Truhan AP; Ahmed AR
    Ann Allergy; 1989 May; 62(5):375-91. PubMed ID: 2655506
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention and treatment of glucocorticoid-induced osteoporosis. A pathogenetic perspective.
    Libanati CR; Baylink DJ
    Chest; 1992 Nov; 102(5):1426-35. PubMed ID: 1424863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and management of glucocorticoid-induced side effects: A comprehensive review: A review of glucocorticoid pharmacology and bone health.
    Caplan A; Fett N; Rosenbach M; Werth VP; Micheletti RG
    J Am Acad Dermatol; 2017 Jan; 76(1):1-9. PubMed ID: 27986132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid-induced osteoporosis in dermatologic practice: a review.
    Khan YK; Kalaaji AN; Clarke BL
    J Drugs Dermatol; 2008 Nov; 7(11):1053-9. PubMed ID: 19110736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term side effects of glucocorticoids.
    Oray M; Abu Samra K; Ebrahimiadib N; Meese H; Foster CS
    Expert Opin Drug Saf; 2016; 15(4):457-65. PubMed ID: 26789102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on glucocorticoid-induced osteoporosis.
    Woolf AD
    Curr Opin Rheumatol; 2007 Jul; 19(4):370-5. PubMed ID: 17551369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immobility in the aged.
    Rousseau P
    Arch Fam Med; 1993 Feb; 2(2):169-77; discussion 178. PubMed ID: 8275186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid-induced osteoporosis: an update for dermatologists.
    Clarke BL
    Am J Clin Dermatol; 2012 Jun; 13(3):167-90. PubMed ID: 22393910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Major side effects of systemic glucocorticoid].
    Kudo C
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():317-21. PubMed ID: 25831775
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic corticosteroid therapy--side effects and their management.
    Stanbury RM; Graham EM
    Br J Ophthalmol; 1998 Jun; 82(6):704-8. PubMed ID: 9797677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safe and appropriate use of systemic glucocorticoids in treating dermatologic disease.
    Werth VP
    J Am Acad Dermatol; 2013 Jan; 68(1):177-8. PubMed ID: 23244375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.